BioSpace News Archive

Drug Development

Results of Phase 3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam) versus Meropenem for Treatment of Adult Patients with Ventilated Nosocomial Pneumonia (VNP) to be Presented at ECCMID 2019

ASPECT-NP Clinical Trial Results Demonstrated Non-Inferiority of ZERBAXA to Meropenem for Treating Ventilated Nosocomial Pneumonia in Primary and Key Secondary Endpoints

April 13, 2019
·
11 min read
Deals

Dr. Reddy’s Laboratories Announces Acquisition of ANDA Portfolio

Dr. Reddy’s Laboratories Ltd. announced that it has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications in the U.S.

April 13, 2019
·
2 min read
Pharm Country

Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older

The Biologics License Application is expected to be submitted to the U.S. FDA by the end of 2020, subject to the successful completion of Phase 3 studies

April 13, 2019
·
13 min read
Policy

/R E P E A T -- Notice to the media - Minister of Health to speak at the Canadian Conference on Medical Education/

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will provide remarks at the Canadian Conference on Medical Education.

April 13, 2019
·
1 min read